{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:50:18Z","timestamp":1786650618713,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharm Bioall Sci"],"published-print":{"date-parts":[[2013]]},"DOI":"10.4103\/0975-7406.116800","type":"journal-article","created":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T07:24:40Z","timestamp":1377156280000},"page":"184","source":"Crossref","is-referenced-by-count":6,"title":["Stability-indicating assay of repaglinide in bulk and optimized nanoemulsion by validated high performance thin layer chromatography technique"],"prefix":"10.4103","volume":"5","author":[{"given":"Mohd","family":"Aqil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juber","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheeba","family":"Fareed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0975-7406.116800-1","unstructured":"Budavari S, Editor. In: The Merck Index. 12 th ed. Whitehouse Station, NJ: Merck and Co., Inc.; 1996."},{"key":"key-10.4103\/0975-7406.116800-2","unstructured":"Martindale RJ. 33 rd ed. The Complete Drug Reference. London: Pharmaceutical Press; 2002."},{"key":"key-10.4103\/0975-7406.116800-3","unstructured":"United State Pharmacopoeia. Asian ed. Rockville MD: USP Convention Inc.; 2003. p. 623."},{"key":"key-10.4103\/0975-7406.116800-4","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.jpba.2006.12.010","article-title":"Method development and validation of repaglinide in human plasma by HPLC and its application in pharmacokinetic studies","author":"Ruzilawati","year":"2007","journal-title":"J Pharm Biomed Anal"},{"key":"key-10.4103\/0975-7406.116800-5","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.2116\/analsci.19.1675","article-title":"Determination of repaglinide in pharmaceutical formulations by HPLC with UV detection","author":"Gandhimathi","year":"2003","journal-title":"Anal Sci"},{"key":"key-10.4103\/0975-7406.116800-6","first-page":"428","article-title":"A simple HPLC method for quantitation of repaglinide in tablet dosage form","author":"Khan","year":"2007","journal-title":"Ind Drugs"},{"key":"key-10.4103\/0975-7406.116800-7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1556\/JPC.18.2005.2.12","article-title":"Quantitative analysis of repaglinide in tablets by reversed-phase thin-layer chromatography with densitometric UV detection","author":"Gumieniczek","year":"2005","journal-title":"J Planar Chromatogr-Mod TLC"},{"key":"key-10.4103\/0975-7406.116800-8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1248\/yakushi.128.171","article-title":"Electrochemical determination of the antidiabetic drug repaglinide","author":"El-Ries","year":"2008","journal-title":"Yakugaku Zasshi"},{"key":"key-10.4103\/0975-7406.116800-9","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/jaoac\/84.4.1265","article-title":"Validation and quality assurance of planar chromatography procedures in pharmaceutical analysis","author":"Ferenczi-Fodor","year":"2001","journal-title":"J AOAC Int"},{"key":"key-10.4103\/0975-7406.116800-10","unstructured":"Ferenczi-Fodor K, Vigh Z. Planar Chromatography: A retrospective view from the third Millennium (Sz. Nyiredy Edt.), Budapest: Springer Scientific Publisher; 2001. p. 336-52."},{"key":"key-10.4103\/0975-7406.116800-11","unstructured":"ICH Guidelines Q2A. Validation of analytical procedure: Methodology, In: International Conference on Harmonization, Geneva; 1994."},{"key":"key-10.4103\/0975-7406.116800-12","unstructured":"ICH Guidelines Q2B. Validation of analytical procedure: Methodology, In: International conference on Harmonization, Geneva; 1996."},{"key":"key-10.4103\/0975-7406.116800-13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2116\/analsci.26.467","article-title":"Stability indicating HPTLC method for determination of terbutaline sulfate in bulk and from submicronized dry powder inhalers","author":"Faiyazuddin","year":"2010","journal-title":"Anal Sci"}],"container-title":["Journal of Pharmacy And Bioallied Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:21:03Z","timestamp":1786648863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0975-7406.116800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"alternative-id":["116800"],"URL":"https:\/\/doi.org\/10.4103\/0975-7406.116800","relation":{},"ISSN":["0975-7406"],"issn-type":[{"value":"0975-7406","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}